BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27658340)

  • 41. [Leukemia cutis in acute promyelocytic leukemia].
    del Río Garma J; Varela Gómez MR; Torres Carrete JP; Batlle Fonrodona FJ
    Sangre (Barc); 1997 Feb; 42(1):87-8. PubMed ID: 9229813
    [No Abstract]   [Full Text] [Related]  

  • 42. Acute promyelocytic leukemia during pregnancy.
    Ganzitti L; Fachechi G; Driul L; Marchesoni D
    Fertil Steril; 2010 Nov; 94(6):2330.e5-6. PubMed ID: 20447623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials).
    Kelaidi C; Ades L; Chevret S; Sanz M; Guerci A; Thomas X; de Botton S; Raffoux E; Rayon C; Fegueux N; Bordessoule D; Rigal-Huguet F; Link H; Stoppa A; Vekhoff A; Meyer-Monard S; Castaigne S; Dombret H; Degos L; Fenaux P
    Leukemia; 2006 May; 20(5):905-7. PubMed ID: 16541143
    [No Abstract]   [Full Text] [Related]  

  • 44. Extramedullary disease in APL: a real phenomenon to contend with or not?
    Ganzel C; Douer D
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):63-8. PubMed ID: 24907018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rare presentation of pediatric acute promyelocytic leukemia as multiple lytic bone lesions: case report and review of literature.
    Nair M; Kusumakumary P; Nair PS
    J Cancer Res Ther; 2014; 10(2):381-3. PubMed ID: 25022399
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study.
    Kwong YL; Au WY; Chim CS; Pang A; Suen C; Liang R
    Am J Hematol; 2001 Apr; 66(4):274-9. PubMed ID: 11279639
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Central nervous system involvement at the time of presentation in acute promyelocytic leukemia.
    Collins C; Knoderer H
    Pediatr Blood Cancer; 2010 Apr; 54(4):603-5. PubMed ID: 19998465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Current therapy for acute myeloid leukemia and acute promyelocytic leukemia].
    Miyawaki S
    Rinsho Ketsueki; 2014 Jan; 55(1):31-41. PubMed ID: 24492035
    [No Abstract]   [Full Text] [Related]  

  • 49. Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group.
    de Botton S; Fawaz A; Chevret S; Dombret H; Thomas X; Sanz M; Guerci A; San Miguel J; de la Serna J; Stoppa AM; Reman O; Stamatoulas A; Fey M; Cahn JY; Sotto JJ; Bourhis JH; Parry A; Chomienne C; Degos L; Fenaux P
    J Clin Oncol; 2005 Jan; 23(1):120-6. PubMed ID: 15534358
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Relapse of gingival tumor during hematological remission in acute promyelocytic leukemia].
    Sawatari T; Kawano F; Akahoshi Y; Asou N; Fujimoto K; Murai C; Taen A; Fukuda S; Ishimaru S; Takatsuki K
    Rinsho Ketsueki; 1989 Nov; 30(11):2020-3. PubMed ID: 2607617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved treatment results for childhood acute myeloid leukemia in Taiwan.
    Liang DC; Chan TT; Lin KH; Lin DT; Lu MY; Chen SH; Liu HC; Lin MT; Lee MT; Shu SG; Chang TK; Chen JS; Hsiao CC; Hung IJ; Hsieh YL; Chen RL; Cheng SN; Chang WH; Lee CH; Lin KS
    Leukemia; 2006 Jan; 20(1):136-41. PubMed ID: 16281075
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current management and new approaches in the treatment of APL.
    Tallman MS
    Clin Adv Hematol Oncol; 2003 Oct; 1(10):580-1. PubMed ID: 16258453
    [No Abstract]   [Full Text] [Related]  

  • 53. Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study.
    Lucena-Araujo AR; Kim HT; Jacomo RH; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; Chauffaille Mde L; Chiattone CS; Lima AS; Ruiz-Argüelles G; Undurraga MS; Martinez L; Kwaan HC; Gallagher R; Niemeyer CM; Schrier SL; Tallman MS; Grimwade D; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Sanz MA; Rego EM
    Ann Hematol; 2014 Dec; 93(12):2001-10. PubMed ID: 24981688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Successful adjuvant therapy of M-CSF with chemotherapy of two cases of chemotherapy resistant acute promyelocytic leukemia].
    Matsushita K; Matsumoto T; Arima N; Hidaka S; Ohtsubo H; Tanaka H
    Rinsho Ketsueki; 1995 Jun; 36(6):621-6. PubMed ID: 7643455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experience.
    Head DR; Kopecky KJ; Willman C; Appelbaum FR
    Leukemia; 1994; 8 Suppl 2():S38-41. PubMed ID: 7815835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute promyelocytic leukemia: a case-based review.
    Gupta V; Tabak D; Keating A
    Hematology; 2003 Apr; 8(2):105-13. PubMed ID: 12745660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Update on the management of pediatric acute promyelocytic leukemia.
    Feusner J; Gregory JJ
    Clin Adv Hematol Oncol; 2006 Nov; 4(11):854-5; author reply 855-6. PubMed ID: 17193721
    [No Abstract]   [Full Text] [Related]  

  • 59. Combined chemotherapy for acute promyelocytic leukemia: a meta-analysis.
    Li X; Wang C; Chen G; Ji B; Xu Y
    Hematology; 2017 Sep; 22(8):450-459. PubMed ID: 28480800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
    Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
    J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.